Form 4 for WVE Wave Life Sciences, Inc.
Accepted 2025-08-07 00:00:00 ET · period of report 2025-08-05 · accession 0000950170-25-105352 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2025-08-07 | 2025-08-05 | WVE | Tan Aik Na | Dir | S - Sale | $8.75 | -1,127 | 15.0K | -7% | -$9,861 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-08-05 | S | D | 1,127 | $8.75 | 14,988 | D | — | — | (F1) On August 5, 2025, the reporting person sold 1,127 ordinary shares solely to cover taxes associated with the vesting of restricted share units on August 5, 2025.These sales were made pursuant to a 10b5-1 Trading Plan. |